Suchergebnisse - "Crivera, Concetta"

PubPharm (151)

1

Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab

enthalten in: Annals of hematology | 2024

von Murakhovskaya, I. | Crivera, C. | Leon, A. | +7

2

Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab

enthalten in: Annals of hematology | 2024

von Murakhovskaya, I. | Crivera, C. | Leon, A. | +7

3

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma

enthalten in: Oncology and therapy | 2023

von Jagannath, S. | Joseph, N. | Crivera, C. | +10

4

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma

enthalten in: Oncology and Therapy | 2023

von Jagannath, S. | Joseph, N. | Crivera, C. | +10

5

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma

enthalten in: Rare Cancers and Therapy | 2023

von Jagannath, S. | Joseph, N. | Crivera, C. | +10

6

Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States

enthalten in: Oncology and therapy | 2022

von Jagannath, S. | Joseph, N. | He, J. | +4

7

Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma

enthalten in: Future oncology (London, England) | 2022

von Hoda, D. | Richards, R. | Faber, E. | +16

8

Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States

enthalten in: Oncology and Therapy | 2022

von Jagannath, S. | Joseph, N. | He, J. | +4

9

Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States

enthalten in: Rare Cancers and Therapy | 2022

von Jagannath, S. | Joseph, N. | He, J. | +4

10

Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma

enthalten in: EJHaem | 2022

von Martin, T. | Krishnan, A. | Yong, K. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]